10 Best Falling Stocks to Invest in Right Now

3. Novo Nordisk A/S (NYSE:NVO)

52 Week Range: $78.17 – $148.15

Current Share Price: $80.57

Number of Hedge Fund Holders: 61

Stock Upside Potential: 41.55%

Novo Nordisk A/S (NYSE:NVO) is a healthcare company that researches, develops, manufactures, and distributes pharmaceutical products. After dropping by about 23% in 2024, it is emerging as one of the best-falling stocks to invest in right now. That’s in part because the company boasts of a robust pipeline of weight loss and diabetes drugs that continue to elicit strong demand.

Novo Nordisk A/S (NYSE:NVO) has delivered consistent growth over the years owing to its expansive offerings that include groundbreaking innovations in diabetes and obesity. In the first nine months of last year, the company delivered a 23% increase in sales attributed to Ozempic and Wegovy sales. The two drugs have cemented the company’s position as a leader in diabetes, with a 34% market share.

While the launch of Wegovy affirms the company’s ability to address emerging challenges in obesity, it has also moved to strengthen its prospects with weight loss treatment CagriSema. While Novo Nordisk A/S (NYSE:NVO) took a hit on CagriSema, helping participants lose an average of 22.7% of weight versus 25% expected, the selloff appears to be an overreaction. With the stock trading near its 52-week low, it seems to be trading at a significant discount, going by the tremendous potential of its weight loss and diabetes treatment options.